Splenic Cell Editing therapy(Westgene Biopharma)

N/A

Report date: 2024/09/29 14:52:21

Base Information

Drug NameSplenic Cell Editing therapy(Westgene Biopharma)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Gene editing
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSplenic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChengdu Westgene Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Westgene Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsSplenic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A